Electrographic Response to Levetiracetam as Second Line Antiseizure Medication In Neonates – A Prospective Multicentric Study (On-Demand Only, Presenter Not in Denver)
Saturday, April 23, 2022
10:30 AM – 10:45 AM US MT
Location: Convention Center: Four Seasons Ballroom 2-3
Publication Number: 1305.3
Vidya Ujjanappa, IPEU, Hubli, Karnataka, India; Hemadriben M. Vegda, International Perinatal Epidemiology Unit Private Limited, Bengaluru, Karnataka, India; Vijay Kumar, Imperial college london, London, England, United Kingdom; Vaisakh Krishnan, Imperial College, London, PALAKKAD, Kerala, India; Vaishnavi M. Bagayi, Perinatal Trials Unit Foundation, HUBLI, Karnataka, India; Nizamuddeen Muneer, International Perinatal Epidemiology Unit, Kannur, Kerala, India; Manu Mohan, International Perinatal Epidemiology Unit, KOTTAYAM, Kerala, India; Sudhindrashayana Fattepur, Karnataka Institute of Medical Sciences, Hubballi, Karnataka, India; Sahana Devadas, Vanivillas children's hospital, Bengaluru, Karnataka, India; Mohandas Nair, Government Medical College, Kozhikode, Kozhikode, Kerala, India; Ashraf Thottoli Puthyapurayil, Government Medical College Kozhikode, kozhikode, Kerala, India; Ajithkumar Vellani Thamunni, Govt medical college kozhikode, Kozhikode, Kerala, India; Gabriel Fernando T. Variane, Santa Casa de Sao Paulo, Sao Paulo, Sao Paulo, Brazil; Paolo Montaldo, Imperial College London, London, England, United Kingdom; Charles Newton, University of Oxford, Oxford, England, United Kingdom; J Helen Cross, UCL Great Ormond Street Institute of Child Health, London, England, United Kingdom; Seetha Shankaran, Wayne State University School of Medicine, Austin, TX, United States; Sudhin Thayyil, Imperial College London, London, England, United Kingdom; Ronit M. Pressler, Great Ormond Street Hospital, London, England, United Kingdom
Presenting Author(s)
Vidya Ujjanappa, MD
Neonatal Neurology Clinical Research Fellow IPEU Hubli, Karnataka, India
Participants should be aware of the following financial/non-financial relationships:
Vidya Ujjanappa, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Hemadriben M. Vegda, M.B.B.S., DNB Pediatrics, Pediatric Neurology: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vijay Kumar, MD DNB Neonatology: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vaisakh Krishnan, MD, DNB: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vaishnavi M. Bagayi, BSc Neuroscience Technology: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Nizamuddeen Muneer, Diploma in Neuro Technician: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Manu Mohan, DIPLOMA IN NEUROTECHNOLOGY: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sudhindrashayana Fattepur, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sahana Devadas, M.B.B.S., M.D. Pediatrics, FIPM: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mohandas Nair, Karippoth, MD Pediatrics: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ashraf Thottoli Puthyapurayil, MD(Ped) DNB (Ped): I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ajithkumar Vellani Thamunni, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Gabriel Fernando T. Variane, Variane, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Paolo Montaldo, Phd, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Charles Newton, MBChB, MD, FRCPCH, FRCP: I do not have any relevant financial / non-financial relationships with any proprietary interests.
J Helen Cross, Cross, MB ChB PhD FRCPCH FRCP: ● Biocodex (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● GW Pharma (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● GW Pharma (Ended In the Past 24 Months) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Marinius (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● Stoke Therapeutics (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator). ● UCB (Ended In the Past 24 Months) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Zogenix (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● Zogenix (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● Zogenix (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
Seetha Shankaran, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sudhin Thayyil, MD, PhD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Ronit M. Pressler, PhD MD: ● Esai (Ended In the Past 24 Months) (Products/Services: Advisory Committee). ● GW (Currently Ongoing) (Products/Services: Advisory Committee). ● Kephala (Currently Ongoing) (Products/Services: Contractor including contracted research). ● NATUS (Currently Ongoing) (Products/Services: Speaker Honorarium including speakers bureau, symposia, and expert witness). ● UCB (Currently Ongoing) (Products/Services: Consultant, Advisory Committee).